{"nctId":"NCT01954394","briefTitle":"Open Label Study of Long Term Safety Evaluation of Alirocumab","startDateStruct":{"date":"2013-12-17"},"conditions":["Hypercholesterolemia"],"count":986,"armGroups":[{"label":"Alirocumab 75 or 150 mg Q2W","type":"EXPERIMENTAL","interventionNames":["Drug: Alirocumab","Drug: Lipid-Modifying Therapy (LMT)"]}],"interventions":[{"name":"Alirocumab","otherNames":["SAR236553","REGN727","Praluent"]},{"name":"Lipid-Modifying Therapy (LMT)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion criteria:\n\nParticipants with heFH who had completed one of the four parent studies (EFC12492, R727-CL-1112, EFC12732 and LTS11717).\n\nExclusion criteria:\n\nSignificant protocol deviation in the parent study; Any permanent treatment discontinuation from the parent study.\n\nThe above information was not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Participants Who Experienced Adverse Events (AEs)","description":"Reported AEs are treatment-emergent AEs that is AEs that developed/worsened during the 'treatment-emergent period' (the time from the first dose of alirocumab in this study up to the last dose of alirocumab received in this study +70 days). Clinically significant lab and vital sign abnormalities were to be reported as AEs.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"83.9","spread":null},{"groupId":"OG001","value":"87.3","spread":null},{"groupId":"OG002","value":"86.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20.6","spread":null},{"groupId":"OG001","value":"22.0","spread":null},{"groupId":"OG002","value":"21.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.0","spread":null},{"groupId":"OG001","value":"3.5","spread":null},{"groupId":"OG002","value":"3.4","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Calculated LDL-C at Weeks 8, 24, 48, 72, 96, 120, 144 and 168","description":"Baseline here corresponds to the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717). Post-baseline on-treatment data was obtained from Week 8 onwards up to Week 168 in this study.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-44.9","spread":"25.9"},{"groupId":"OG001","value":"-43.8","spread":"28.7"},{"groupId":"OG002","value":"-44.2","spread":"27.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-46.9","spread":"27.5"},{"groupId":"OG001","value":"-46.9","spread":"29.3"},{"groupId":"OG002","value":"-46.9","spread":"28.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-45.6","spread":"28.0"},{"groupId":"OG001","value":"-47.5","spread":"28.8"},{"groupId":"OG002","value":"-46.9","spread":"28.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-47.7","spread":"23.5"},{"groupId":"OG001","value":"-47.3","spread":"28.4"},{"groupId":"OG002","value":"-47.4","spread":"26.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-47.4","spread":"23.8"},{"groupId":"OG001","value":"-48.2","spread":"28.2"},{"groupId":"OG002","value":"-47.9","spread":"26.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-47.4","spread":"24.0"},{"groupId":"OG001","value":"-46.6","spread":"31.1"},{"groupId":"OG002","value":"-46.8","spread":"28.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-46.5","spread":"25.8"},{"groupId":"OG001","value":"-49.6","spread":"24.6"},{"groupId":"OG002","value":"-48.5","spread":"25.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-43.6","spread":"13.4"},{"groupId":"OG001","value":"-52.2","spread":"20.7"},{"groupId":"OG002","value":"-48.8","spread":"17.8"}]}]}]},{"type":"SECONDARY","title":"Absolute Change From Baseline in Calculated LDL-C (mg/dL) at Weeks 8, 24, 48, 72, 96, 120, 144 and 168","description":"Baseline here corresponds to the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717). Post-baseline on-treatment data was obtained from Week 8 onwards up to Week 168 in this study.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-66.8","spread":"45.6"},{"groupId":"OG001","value":"-67.1","spread":"49.2"},{"groupId":"OG002","value":"-67.0","spread":"48.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-70.3","spread":"49.5"},{"groupId":"OG001","value":"-72.7","spread":"52.4"},{"groupId":"OG002","value":"-71.9","spread":"51.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-67.8","spread":"49.7"},{"groupId":"OG001","value":"-73.9","spread":"54.3"},{"groupId":"OG002","value":"-71.9","spread":"52.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-71.2","spread":"44.5"},{"groupId":"OG001","value":"-74.9","spread":"54.5"},{"groupId":"OG002","value":"-73.7","spread":"51.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-70.2","spread":"45.9"},{"groupId":"OG001","value":"-75.9","spread":"55.0"},{"groupId":"OG002","value":"-74.0","spread":"52.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-72.3","spread":"45.6"},{"groupId":"OG001","value":"-75.2","spread":"59.7"},{"groupId":"OG002","value":"-74.2","spread":"55.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-73.1","spread":"50.0"},{"groupId":"OG001","value":"-86.2","spread":"57.8"},{"groupId":"OG002","value":"-81.6","spread":"55.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-66.1","spread":"24.7"},{"groupId":"OG001","value":"-99.4","spread":"48.3"},{"groupId":"OG002","value":"-86.1","spread":"42.4"}]}]}]},{"type":"SECONDARY","title":"Absolute Change From Baseline in Calculated LDL-C (mmol/L) at Weeks 8, 24, 48, 72, 96, 120, 144 and 168","description":"Baseline here corresponds to the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717). Post-baseline on-treatment data was obtained from Week 8 onwards up to Week 168 in this study.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.729","spread":"1.180"},{"groupId":"OG001","value":"-1.738","spread":"1.273"},{"groupId":"OG002","value":"-1.735","spread":"1.242"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.821","spread":"1.282"},{"groupId":"OG001","value":"-1.883","spread":"1.356"},{"groupId":"OG002","value":"-1.863","spread":"1.332"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.757","spread":"1.286"},{"groupId":"OG001","value":"-1.914","spread":"1.405"},{"groupId":"OG002","value":"-1.861","spread":"1.368"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.843","spread":"1.154"},{"groupId":"OG001","value":"-1.940","spread":"1.411"},{"groupId":"OG002","value":"-1.908","spread":"1.332"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.818","spread":"1.190"},{"groupId":"OG001","value":"-1.965","spread":"1.426"},{"groupId":"OG002","value":"-1.916","spread":"1.353"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.874","spread":"1.180"},{"groupId":"OG001","value":"-1.949","spread":"1.546"},{"groupId":"OG002","value":"-1.923","spread":"1.428"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.894","spread":"1.294"},{"groupId":"OG001","value":"-2.232","spread":"1.498"},{"groupId":"OG002","value":"-2.114","spread":"1.436"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.712","spread":"0.641"},{"groupId":"OG001","value":"-2.574","spread":"1.252"},{"groupId":"OG002","value":"-2.229","spread":"1.098"}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants Reaching Calculated LDL-C <100 mg/dL (2.59 mmol/L) Over Time","description":"Baseline here corresponds to the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717). Post-baseline on-treatment data was obtained from Week 8 onwards up to Week 168 in this study.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12.1","spread":null},{"groupId":"OG001","value":"11.5","spread":null},{"groupId":"OG002","value":"11.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"71.0","spread":null},{"groupId":"OG001","value":"86.1","spread":null},{"groupId":"OG002","value":"81.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"77.0","spread":null},{"groupId":"OG001","value":"75.7","spread":null},{"groupId":"OG002","value":"76.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"77.7","spread":null},{"groupId":"OG001","value":"76.4","spread":null},{"groupId":"OG002","value":"76.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"82.9","spread":null},{"groupId":"OG001","value":"77.6","spread":null},{"groupId":"OG002","value":"79.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"79.2","spread":null},{"groupId":"OG001","value":"76.8","spread":null},{"groupId":"OG002","value":"77.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"78.2","spread":null},{"groupId":"OG001","value":"76.7","spread":null},{"groupId":"OG002","value":"77.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"72.5","spread":null},{"groupId":"OG001","value":"74.4","spread":null},{"groupId":"OG002","value":"73.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.0","spread":null},{"groupId":"OG001","value":"83.3","spread":null},{"groupId":"OG002","value":"80.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants Reaching Calculated LDL-C <70 mg/dL (1.81 mmol/L) Over Time","description":"Baseline here corresponds to the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717). Post-baseline on-treatment data was obtained from Week 8 onwards up to Week 168 in this study.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":null},{"groupId":"OG001","value":"1.2","spread":null},{"groupId":"OG002","value":"1.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"47.4","spread":null},{"groupId":"OG001","value":"66.4","spread":null},{"groupId":"OG002","value":"60.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"53.4","spread":null},{"groupId":"OG001","value":"53.1","spread":null},{"groupId":"OG002","value":"53.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"51.1","spread":null},{"groupId":"OG001","value":"53.5","spread":null},{"groupId":"OG002","value":"52.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"57.0","spread":null},{"groupId":"OG001","value":"53.2","spread":null},{"groupId":"OG002","value":"54.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"53.0","spread":null},{"groupId":"OG001","value":"56.4","spread":null},{"groupId":"OG002","value":"55.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"52.7","spread":null},{"groupId":"OG001","value":"50.9","spread":null},{"groupId":"OG002","value":"51.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"46.4","spread":null},{"groupId":"OG001","value":"48.1","spread":null},{"groupId":"OG002","value":"47.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"50.0","spread":null},{"groupId":"OG001","value":"33.3","spread":null},{"groupId":"OG002","value":"40.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants With Calculated LDL-C <70 mg/dL (1.81mmol/L) and/or >=50% Reduction in Calculated LDL-C From Baseline (if Calculated LDL-C >=70 mg/dL [1.81mmol/L]) Over Time","description":"Baseline here corresponds to the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717). Post-baseline on-treatment data was obtained from Week 8 onwards up to Week 168 in this study.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":null},{"groupId":"OG001","value":"1.2","spread":null},{"groupId":"OG002","value":"1.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"49.5","spread":null},{"groupId":"OG001","value":"67.1","spread":null},{"groupId":"OG002","value":"61.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"54.1","spread":null},{"groupId":"OG001","value":"54.3","spread":null},{"groupId":"OG002","value":"54.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"52.1","spread":null},{"groupId":"OG001","value":"54.5","spread":null},{"groupId":"OG002","value":"53.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"57.3","spread":null},{"groupId":"OG001","value":"54.4","spread":null},{"groupId":"OG002","value":"55.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"53.0","spread":null},{"groupId":"OG001","value":"57.7","spread":null},{"groupId":"OG002","value":"56.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"53.2","spread":null},{"groupId":"OG001","value":"53.1","spread":null},{"groupId":"OG002","value":"53.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"46.4","spread":null},{"groupId":"OG001","value":"48.8","spread":null},{"groupId":"OG002","value":"48.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"50.0","spread":null},{"groupId":"OG001","value":"33.3","spread":null},{"groupId":"OG002","value":"40.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Non-High Density Lipoprotein Cholesterol (Non-HDL-C) at Weeks 8, 24, 48, 72, 96, 120, 144 and 168","description":"Baseline here corresponds to the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717). Post-baseline on-treatment data was obtained from Week 8 onwards up to Week 168 in this study.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-38.1","spread":"24.8"},{"groupId":"OG001","value":"-37.6","spread":"26.6"},{"groupId":"OG002","value":"-37.8","spread":"26.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-40.6","spread":"25.5"},{"groupId":"OG001","value":"-40.4","spread":"27.9"},{"groupId":"OG002","value":"-40.5","spread":"27.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-39.7","spread":"25.5"},{"groupId":"OG001","value":"-40.6","spread":"27.6"},{"groupId":"OG002","value":"-40.3","spread":"26.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-40.8","spread":"22.6"},{"groupId":"OG001","value":"-40.3","spread":"26.5"},{"groupId":"OG002","value":"-40.5","spread":"25.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-39.9","spread":"23.5"},{"groupId":"OG001","value":"-40.5","spread":"26.6"},{"groupId":"OG002","value":"-40.3","spread":"25.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-41.4","spread":"22.1"},{"groupId":"OG001","value":"-38.4","spread":"29.7"},{"groupId":"OG002","value":"-39.5","spread":"27.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-39.8","spread":"22.9"},{"groupId":"OG001","value":"-41.8","spread":"24.0"},{"groupId":"OG002","value":"-41.1","spread":"23.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-40.7","spread":"12.3"},{"groupId":"OG001","value":"-47.7","spread":"18.8"},{"groupId":"OG002","value":"-44.9","spread":"16.1"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total-cholesterol at Weeks 8, 24, 48, 72, 96, 120, 144 and 168","description":"Baseline here corresponds to the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717). Post-baseline on-treatment data was obtained from Week 8 onwards up to Week 168 in this study.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-27.9","spread":"19.3"},{"groupId":"OG001","value":"-27.7","spread":"20.7"},{"groupId":"OG002","value":"-27.7","spread":"20.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-30.1","spread":"20.3"},{"groupId":"OG001","value":"-30.2","spread":"21.6"},{"groupId":"OG002","value":"-30.1","spread":"21.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-29.0","spread":"20.5"},{"groupId":"OG001","value":"-30.0","spread":"21.6"},{"groupId":"OG002","value":"-29.7","spread":"21.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-29.9","spread":"18.0"},{"groupId":"OG001","value":"-30.1","spread":"20.8"},{"groupId":"OG002","value":"-30.0","spread":"19.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-28.9","spread":"18.3"},{"groupId":"OG001","value":"-29.9","spread":"21.1"},{"groupId":"OG002","value":"-29.6","spread":"20.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-30.2","spread":"17.2"},{"groupId":"OG001","value":"-28.4","spread":"22.8"},{"groupId":"OG002","value":"-29.0","spread":"21.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-29.1","spread":"18.2"},{"groupId":"OG001","value":"-31.3","spread":"19.1"},{"groupId":"OG002","value":"-30.5","spread":"18.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-32.3","spread":"12.4"},{"groupId":"OG001","value":"-39.1","spread":"14.3"},{"groupId":"OG002","value":"-36.4","spread":"13.3"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in High Density Lipoprotein Cholesterol (HDL-C) at Weeks 8, 24, 48, 72, 96, 120, 144 and 168","description":"Baseline here corresponds to the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717). Post-baseline on-treatment data was obtained from Week 8 onwards up to Week 168 in this study.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.6","spread":"17.1"},{"groupId":"OG001","value":"6.6","spread":"17.3"},{"groupId":"OG002","value":"6.3","spread":"17.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.7","spread":"17.4"},{"groupId":"OG001","value":"5.8","spread":"16.9"},{"groupId":"OG002","value":"5.8","spread":"17.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.1","spread":"17.8"},{"groupId":"OG001","value":"7.2","spread":"19.2"},{"groupId":"OG002","value":"7.2","spread":"18.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.7","spread":"17.6"},{"groupId":"OG001","value":"7.2","spread":"19.9"},{"groupId":"OG002","value":"7.0","spread":"19.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.2","spread":"18.8"},{"groupId":"OG001","value":"7.2","spread":"18.7"},{"groupId":"OG002","value":"7.2","spread":"18.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.0","spread":"18.4"},{"groupId":"OG001","value":"8.1","spread":"18.7"},{"groupId":"OG002","value":"8.1","spread":"18.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.8","spread":"19.2"},{"groupId":"OG001","value":"8.8","spread":"24.8"},{"groupId":"OG002","value":"8.8","spread":"23.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.6","spread":"26.2"},{"groupId":"OG001","value":"-0.3","spread":"9.9"},{"groupId":"OG002","value":"-2.8","spread":"17.1"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Fasting Triglycerides (TGs) at Weeks 8, 24, 48, 72, 96, 120, 144 and 168","description":"Baseline here corresponds to the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717). Post-baseline on-treatment data was obtained from Week 8 onwards up to Week 168 in this study.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.4","spread":"40.5"},{"groupId":"OG001","value":"3.5","spread":"47.0"},{"groupId":"OG002","value":"3.5","spread":"44.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.6","spread":"39.9"},{"groupId":"OG001","value":"1.0","spread":"45.9"},{"groupId":"OG002","value":"0.9","spread":"44.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":"37.5"},{"groupId":"OG001","value":"5.1","spread":"78.0"},{"groupId":"OG002","value":"3.7","spread":"67.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.3","spread":"43.3"},{"groupId":"OG001","value":"3.6","spread":"42.9"},{"groupId":"OG002","value":"3.8","spread":"43.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.1","spread":"53.2"},{"groupId":"OG001","value":"9.3","spread":"55.2"},{"groupId":"OG002","value":"9.2","spread":"54.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.2","spread":"35.3"},{"groupId":"OG001","value":"10.8","spread":"48.5"},{"groupId":"OG002","value":"6.7","spread":"44.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.0","spread":"38.0"},{"groupId":"OG001","value":"7.7","spread":"49.8"},{"groupId":"OG002","value":"6.8","spread":"45.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-22.1","spread":"21.9"},{"groupId":"OG001","value":"-10.3","spread":"27.1"},{"groupId":"OG002","value":"-15.0","spread":"24.6"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Lipoprotein (a) at Weeks 48, 96, 144 and 168","description":"Baseline here corresponds to the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717). Post-baseline on-treatment data was obtained from Week 8 onwards up to Week 168 in this study.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-15.0","spread":"158.4"},{"groupId":"OG001","value":"-26.4","spread":"40.2"},{"groupId":"OG002","value":"-22.6","spread":"97.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.9","spread":"171.7"},{"groupId":"OG001","value":"-21.4","spread":"132.7"},{"groupId":"OG002","value":"-18.9","spread":"146.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-20.1","spread":"46.1"},{"groupId":"OG001","value":"-33.0","spread":"25.0"},{"groupId":"OG002","value":"-28.5","spread":"34.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-30.3","spread":"18.2"},{"groupId":"OG001","value":"-29.2","spread":"15.4"},{"groupId":"OG002","value":"-29.6","spread":"15.6"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein-B (Apo-B) at Weeks 48, 96, 144, and 168","description":"Baseline here corresponds to the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717). Post-baseline on-treatment data was obtained from Week 8 onwards up to Week 168 in this study.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-36.9","spread":"21.7"},{"groupId":"OG001","value":"-37.8","spread":"23.4"},{"groupId":"OG002","value":"-37.5","spread":"22.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-36.9","spread":"20.9"},{"groupId":"OG001","value":"-38.0","spread":"22.9"},{"groupId":"OG002","value":"-37.6","spread":"22.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-33.9","spread":"20.9"},{"groupId":"OG001","value":"-36.9","spread":"21.3"},{"groupId":"OG002","value":"-35.9","spread":"21.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-38.0","spread":"9.0"},{"groupId":"OG001","value":"-43.1","spread":"20.7"},{"groupId":"OG002","value":"-41.1","spread":"16.5"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Apolipoprotein A-1 (Apo A-1) at Weeks 48, 96, 144, and 168","description":"Baseline here corresponds to the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717). Post-baseline on-treatment data was obtained from Week 8 onwards up to Week 168 in this study.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.6","spread":"14.5"},{"groupId":"OG001","value":"5.8","spread":"17.2"},{"groupId":"OG002","value":"5.7","spread":"16.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.8","spread":"15.4"},{"groupId":"OG001","value":"8.5","spread":"14.1"},{"groupId":"OG002","value":"8.3","spread":"14.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.2","spread":"16.3"},{"groupId":"OG001","value":"10.2","spread":"18.7"},{"groupId":"OG002","value":"10.6","spread":"17.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"19.3"},{"groupId":"OG001","value":"3.9","spread":"9.3"},{"groupId":"OG002","value":"2.7","spread":"13.2"}]}]}]},{"type":"SECONDARY","title":"Absolute Change From Baseline in Apo B/Apo A-1 Ratio at Weeks 48, 96, 144, and 168","description":"Baseline here corresponds to the baseline in the parent study (EFC12492, R727-CL-1112, EFC12732 or LTS11717). Post-baseline on-treatment data was obtained from Week 8 onwards up to Week 168 in this study.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.340","spread":"0.245"},{"groupId":"OG001","value":"-0.361","spread":"0.304"},{"groupId":"OG002","value":"-0.354","spread":"0.286"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.340","spread":"0.228"},{"groupId":"OG001","value":"-0.375","spread":"0.268"},{"groupId":"OG002","value":"-0.363","spread":"0.256"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.342","spread":"0.242"},{"groupId":"OG001","value":"-0.414","spread":"0.433"},{"groupId":"OG002","value":"-0.389","spread":"0.379"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.370","spread":"0.161"},{"groupId":"OG001","value":"-0.498","spread":"0.280"},{"groupId":"OG002","value":"-0.447","spread":"0.238"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":68,"n":330},"commonTop":["Viral upper respiratory tract infection","Upper respiratory tract infection","Influenza","Arthralgia","Back pain"]}}}